References
- Rabih Halabi, Trastuzumab induced sarcoidosis mimicking metastatic carcinoma, CHEST 2011; 140:56A.
- Dmitriy Cogan, A case of trastuzumab induced Pulmonary Sarcoidosis, CHEST, https://doi.org/10.1378/chest.1386625
- P.T. Nigo, A case of trastuzumab induced sarcoidosis, American Society International Conference abstracts, 2017
- Cooner WH, Mosley BR, Rutherford CL, Beard JH, Pond HS, Bass RB, Terry WJ, Igel TC, Kidd DD. Prostate cancer detection in a clonical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 1990; 143: 1146.
- Stamey TA, Kabalin JN. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients. J Urol 1989; 141: 1070.
- Yamamoto S, Ito T, Akiyama A, Aizawa T, Miki M, Tachibana M. M1 prostate cancer with a serum level of prostate-specific antigen less than 10 ng/ml. Int J Urol 2001; 8: 374.
- Gkonos PJ, Krongrad A, Roos BA. Neuroendocrine peptides in the prostate. Urol Res 1995; 23: 81.
- Kimura N, Hoshi S, Takahashi M et al. Plasma chromogranin A in prostatic carcinoma and neuroendocrine tumors. J Urol 1997; 157: 565.
- Aparicio A.M. Harzstark A.L. Corn P.G. et al. Platinum-based chemotherapy for variant castrate-resistant prostate cancer. Clin Cancer Res. 2013; 19: 3621–3630